Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Erratum to: What does a good night's sleep mean? Nonlinear relations between sleep and children's cognitive functioning and mental health.

El-Sheikh M, Philbrook LE, Kelly RJ, Hinnant JB, Buckhalt JA.

Sleep. 2019 Oct 8. pii: zsz195. doi: 10.1093/sleep/zsz195. [Epub ahead of print] No abstract available.

PMID:
31593587
2.

Emerging Multimodality Approaches to Treat Localized Esophageal Cancer.

Kelly RJ.

J Natl Compr Canc Netw. 2019 Aug 1;17(8):1009-1014. doi: 10.6004/jnccn.2019.7337. Review.

PMID:
31390584
3.

Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma.

Babar L, Kosovec JE, Jahangiri V, Chowdhury N, Zheng P, Omstead AN, Salvitti MS, Smith MA, Goel A, Kelly RJ, Jobe BA, Zaidi AH.

Oncotarget. 2019 Jul 16;10(44):4546-4555. doi: 10.18632/oncotarget.27052. eCollection 2019 Jul 16.

4.

Variability and profiles of lipophilic toxins in bivalves from Great Britain during five and a half years of monitoring: azaspiracids and yessotoxins.

Dhanji-Rapkova M, O'Neill A, Maskrey BH, Coates L, Swan SC, Teixeira Alves M, Kelly RJ, Hatfield RG, Rowland-Pilgrim SJ, Lewis AM, Turner AD.

Harmful Algae. 2019 Jul;87:101629. doi: 10.1016/j.hal.2019.101629. Epub 2019 Jul 2.

PMID:
31349886
5.

The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis.

Suresh K, Naidoo J, Zhong Q, Xiong Y, Mammen J, de Flores MV, Cappelli L, Balaji A, Palmer T, Forde PM, Anagnostou V, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Lin CT, Feller-Kopman D, Lerner AD, Lee H, Shafiq M, Yarmus L, Lipson EJ, Soloski M, Brahmer JR, Danoff SK, D'Alessio F.

J Clin Invest. 2019 Jul 16;130:4305-4315. doi: 10.1172/JCI128654.

6.

Targeting the Hedgehog Pathway Using Itraconazole to Prevent Progression of Barrett's Esophagus to Invasive Esophageal Adenocarcinoma.

Kelly RJ, Ansari AM, Miyashita T, Zahurak M, Lay F, Ahmed AK, Born LJ, Pezhouh MK, Salimian KJ, Ng C, Matsangos AE, Stricker-Krongrad AH, Mukaisho KI, Marti GP, Chung CH, Canto MI, Rudek MA, Meltzer SJ, Harmon JW.

Ann Surg. 2019 Jul 8. doi: 10.1097/SLA.0000000000003455. [Epub ahead of print]

PMID:
31290765
7.

Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21.

Müller LME, Holmes M, Michael JL, Scott GB, West EJ, Scott KJ, Parrish C, Hall K, Stäble S, Jennings VA, Cullen M, McConnell S, Langton C, Tidswell EL, Shafren D, Samson A, Harrington KJ, Pandha H, Ralph C, Kelly RJ, Cook G, Melcher AA, Errington-Mais F.

J Immunother Cancer. 2019 Jul 1;7(1):164. doi: 10.1186/s40425-019-0632-y.

8.

Complications and Economic Burden Associated With Obtaining Tissue for Diagnosis and Molecular Analysis in Patients With Non-Small-Cell Lung Cancer in the United States.

Kelly RJ, Turner R, Chen YW, Rigas JR, Fernandes AW, Karve S.

J Oncol Pract. 2019 Aug;15(8):e717-e727. doi: 10.1200/JOP.18.00762. Epub 2019 Jun 25.

PMID:
31237806
9.

A phase III, randomized, open-label study of ASP8273 versus erlotinib or gefitinib in patients with advanced stage IIIB/IV non-small-cell lung cancer.

Kelly RJ, Shepherd FA, Krivoshik A, Jie F, Horn L.

Ann Oncol. 2019 Jul 1;30(7):1127-1133. doi: 10.1093/annonc/mdz128.

10.

The emerging role of immunotherapy for esophageal cancer.

Kelly RJ.

Curr Opin Gastroenterol. 2019 Apr 30. doi: 10.1097/MOG.0000000000000542. [Epub ahead of print]

PMID:
31045596
11.

Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer.

Voong KR, Hazell SZ, Fu W, Hu C, Lin CT, Ding K, Suresh K, Hayman J, Hales RK, Alfaifi S, Marrone KA, Levy B, Hann CL, Ettinger DS, Feliciano JL, Peterson V, Kelly RJ, Brahmer JR, Forde PM, Naidoo J.

Clin Lung Cancer. 2019 Jul;20(4):e470-e479. doi: 10.1016/j.cllc.2019.02.018. Epub 2019 Mar 28.

PMID:
31031204
12.

What does a good night's sleep mean? Nonlinear relations between sleep and children's cognitive functioning and mental health.

El-Sheikh M, Philbrook LE, Kelly RJ, Hinnant JB, Buckhalt JA.

Sleep. 2019 Jun 11;42(6). pii: zsz078. doi: 10.1093/sleep/zsz078.

PMID:
30946458
13.

Interactions between sleep duration and quality as predictors of adolescents' adjustment.

El-Sheikh M, Saini EK, Gillis BT, Kelly RJ.

Sleep Health. 2019 Apr;5(2):180-186. doi: 10.1016/j.sleh.2018.11.004. Epub 2019 Jan 14.

PMID:
30928119
14.

Nissen Fundoplication-Preserving Laparoscopic Sleeve Gastrectomy.

Smith CR, Gardner JT, Vaughn LH, Kelly RJ, Whipple OC.

Am Surg. 2019 Feb 1;85(2):173-176.

PMID:
30819294
15.

Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy.

Suresh K, Psoter KJ, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, Hales RK, D'Alessio F, Danoff SK, Naidoo J.

J Thorac Oncol. 2019 Mar;14(3):494-502. doi: 10.1016/j.jtho.2018.11.016. Epub 2018 Nov 30.

PMID:
30503891
16.

α-galactosidase A deficiency promotes von Willebrand factor secretion in models of Fabry disease.

Kang JJ, Kaissarian NM, Desch KC, Kelly RJ, Shu L, Bodary PF, Shayman JA.

Kidney Int. 2019 Jan;95(1):149-159. doi: 10.1016/j.kint.2018.08.033. Epub 2018 Nov 22.

17.

Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors.

Suresh K, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, D'Alessio F, Hales RK, Lin CT, Psoter KJ, Danoff SK, Naidoo J.

J Thorac Oncol. 2018 Dec;13(12):1930-1939. doi: 10.1016/j.jtho.2018.08.2035. Epub 2018 Sep 26.

PMID:
30267842
18.

Dabrafenib and trametinib for the treatment of non-small cell lung cancer.

Kelly RJ.

Expert Rev Anticancer Ther. 2018 Nov;18(11):1063-1068. doi: 10.1080/14737140.2018.1521272. Epub 2018 Sep 13. Review.

PMID:
30198802
19.

Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development.

Omstead AN, Kosovec JE, Matsui D, Martin SA, Smith MA, Aaron Guel D, Kolano J, Komatsu Y, Habib F, Lai C, Christopher K, Kelly RJ, Zaidi AH, Jobe BA.

Cancer Invest. 2018;36(7):363-370. doi: 10.1080/07357907.2018.1499029. Epub 2018 Aug 24.

PMID:
30142016
20.

Variability and profiles of lipophilic toxins in bivalves from Great Britain during five and a half years of monitoring: Okadaic acid, dinophysis toxins and pectenotoxins.

Dhanji-Rapkova M, O'Neill A, Maskrey BH, Coates L, Teixeira Alves M, Kelly RJ, Hatfield RG, Rowland-Pilgrim SJ, Lewis AM, Algoet M, Turner AD.

Harmful Algae. 2018 Jul;77:66-80. doi: 10.1016/j.hal.2018.05.011. Epub 2018 Jun 19.

PMID:
30005803
21.

Family Functioning and Children's Sleep.

El-Sheikh M, Kelly RJ.

Child Dev Perspect. 2017 Dec;11(4):264-269. doi: 10.1111/cdep.12243. Epub 2017 Jul 21.

22.

Single agent anti PD-1 inhibitors in esophageal cancer-a first step in a new therapeutic direction.

Walsh EM, Kelly RJ.

J Thorac Dis. 2018 Mar;10(3):1308-1313. doi: 10.21037/jtd.2018.03.43. No abstract available.

23.

Reciprocal Relations Between Parental Problem Drinking and Children's Sleep: The Role of Socioeconomic Adversity.

Kelly RJ, El-Sheikh M.

Child Dev. 2018 Apr 18. doi: 10.1111/cdev.13074. [Epub ahead of print]

24.

Maternal immunization increases nestling energy expenditure, immune function, and fledging success in a passerine bird.

Burness G, Moher D, Ben-Ezra N, Kelly RJ, Hasselquist D, Chin EH.

Biol Open. 2018 Apr 4;7(4). pii: bio028803. doi: 10.1242/bio.028803.

25.

Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer.

Gerber DE, Socinski MA, Neal JW, Wakelee HA, Shirai K, Sequist LV, Rosovsky RP, Lilenbaum RC, Bastos BR, Huang C, Johnson ML, Hesketh PJ, Subramaniam DS, Dietrich MF, Chai F, Wang Y, Kazakin J, Schwartz B, Schiller JH, Brahmer JR, Kelly RJ.

Lung Cancer. 2018 Mar;117:44-49. doi: 10.1016/j.lungcan.2018.01.010. Epub 2018 Feb 3.

26.

A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer.

Marrone KA, Zhou X, Forde PM, Purtell M, Brahmer JR, Hann CL, Kelly RJ, Coleman B, Gabrielson E, Rosner GL, Ettinger DS.

Oncologist. 2018 Jul;23(7):859-865. doi: 10.1634/theoncologist.2017-0465. Epub 2018 Feb 27.

27.

Metastatic joint involvement or inflammatory arthritis? A conundrum with immune checkpoint inhibitor-related adverse events.

Albayda J, Bingham CO 3rd, Shah AA, Kelly RJ, Cappelli L.

Rheumatology (Oxford). 2018 Apr 1;57(4):760-762. doi: 10.1093/rheumatology/kex470. No abstract available.

28.

Corneal ulcers in general practice.

Arbabi EM, Kelly RJ, Carrim ZI.

Br J Gen Pract. 2018 Jan;68(666):49-50. doi: 10.3399/bjgp17X694385. No abstract available.

29.

CDK4/6 dual inhibitor abemaciclib demonstrates compelling preclinical activity against esophageal adenocarcinoma: a novel therapeutic option for a deadly disease.

Kosovec JE, Zaidi AH, Omstead AN, Matsui D, Biedka MJ, Cox EJ, Campbell PT, Biederman RWW, Kelly RJ, Jobe BA.

Oncotarget. 2017 Nov 1;8(59):100421-100432. doi: 10.18632/oncotarget.22244. eCollection 2017 Nov 21.

30.

Challenges, Perceptions, and Readiness of Oncology Clinicians for the MACRA Quality Payment Program.

Nabhan C, Jeune-Smith Y, Klinefelter P, Kelly RJ, Feinberg BA.

JAMA Oncol. 2018 Feb 1;4(2):252-253. doi: 10.1001/jamaoncol.2017.3773. No abstract available.

31.

The management of localized esophageal squamous cell carcinoma: Western approach.

Zaidi N, Kelly RJ.

Chin Clin Oncol. 2017 Oct;6(5):46. doi: 10.21037/cco.2017.07.07. Review.

32.

A Comparison of Walking Gait Following Mechanical and Kinematic Alignment in Total Knee Joint Replacement.

McNair PJ, Boocock MG, Dominick ND, Kelly RJ, Farrington BJ, Young SW.

J Arthroplasty. 2018 Feb;33(2):560-564. doi: 10.1016/j.arth.2017.09.031. Epub 2017 Sep 21.

PMID:
29054726
33.

High yield reproducible rat model recapitulating human Barrett's carcinogenesis.

Matsui D, Omstead AN, Kosovec JE, Komatsu Y, Lloyd EJ, Raphael H, Kelly RJ, Zaidi AH, Jobe BA.

World J Gastroenterol. 2017 Sep 7;23(33):6077-6087. doi: 10.3748/wjg.v23.i33.6077.

34.

A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non-small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations.

Yu HA, Spira A, Horn L, Weiss J, West H, Giaccone G, Evans T, Kelly RJ, Desai B, Krivoshik A, Moran D, Poondru S, Jie F, Aoyama K, Keating A, Oxnard GR.

Clin Cancer Res. 2017 Dec 15;23(24):7467-7473. doi: 10.1158/1078-0432.CCR-17-1447. Epub 2017 Sep 27.

35.

The Dynamic and Transient Immune Microenvironment in Locally Advanced Esophageal Adenocarcinoma Post Chemoradiation.

Kelly RJ, Zaidi AH, Smith MA, Omstead AN, Kosovec JE, Matsui D, Martin SA, DiCarlo C, Werts ED, Silverman JF, Wang DH, Jobe BA.

Ann Surg. 2018 Dec;268(6):992-999. doi: 10.1097/SLA.0000000000002410.

PMID:
28806299
36.

Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature.

Craddock CF, Houlton AE, Quek LS, Ferguson P, Gbandi E, Roberts C, Metzner M, Garcia-Martin N, Kennedy A, Hamblin A, Raghavan M, Nagra S, Dudley L, Wheatley K, McMullin MF, Pillai SP, Kelly RJ, Siddique S, Dennis M, Cavenagh JD, Vyas P.

Clin Cancer Res. 2017 Nov 1;23(21):6430-6440. doi: 10.1158/1078-0432.CCR-17-1423. Epub 2017 Aug 1.

37.

Scientific Advances in Thoracic Oncology 2016.

Soo RA, Stone ECA, Cummings KM, Jett JR, Field JK, Groen HJM, Mulshine JL, Yatabe Y, Bubendorf L, Dacic S, Rami-Porta R, Detterbeck FC, Lim E, Asamura H, Donington J, Wakelee HA, Wu YL, Higgins K, Senan S, Solomon B, Kim DW, Johnson M, Yang JCH, Sequist LV, Shaw AT, Ahn MJ, Costa DB, Patel JD, Horn L, Gettinger S, Peters S, Wynes MW, Faivre-Finn C, Rudin CM, Tsao A, Baas P, Kelly RJ, Leighl NB, Scagliotti GV, Gandara DR, Hirsch FR, Spigel DR.

J Thorac Oncol. 2017 Aug;12(8):1183-1209. doi: 10.1016/j.jtho.2017.05.019. Epub 2017 Jun 1. Review.

38.

Immunotherapy for Esophageal and Gastric Cancer.

Kelly RJ.

Am Soc Clin Oncol Educ Book. 2017;37:292-300. doi: 10.14694/EDBK_175231. Review.

PMID:
28561677
39.

The Evolving Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancer.

Murphy AG, Kelly RJ.

Hematol Oncol Clin North Am. 2017 Jun;31(3):485-498. doi: 10.1016/j.hoc.2017.01.007. Epub 2017 Mar 30. Review.

PMID:
28501089
40.

Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.

Matsui D, Zaidi AH, Martin SA, Omstead AN, Kosovec JE, Huleihel L, Saldin LT, DiCarlo C, Silverman JF, Hoppo T, Finley GG, Badylak SF, Kelly RJ, Jobe BA.

Oncotarget. 2016 Dec 6;7(49):81281-81291. doi: 10.18632/oncotarget.12832. Review.

41.

Checkpoint Inhibitors in Lung Cancer Are Not Immune from Cost-Effectiveness Analysis.

Kelly RJ, Smith TJ.

J Thorac Oncol. 2016 Nov;11(11):1814-1816. doi: 10.1016/j.jtho.2016.07.028. No abstract available.

42.

PI3K/mTOR Dual Inhibitor, LY3023414, Demonstrates Potent Antitumor Efficacy Against Esophageal Adenocarcinoma in a Rat Model.

Zaidi AH, Kosovec JE, Matsui D, Omstead AN, Raj M, Rao RR, Biederman RWW, Finley GG, Landreneau RJ, Kelly RJ, Jobe BA.

Ann Surg. 2017 Jul;266(1):91-98. doi: 10.1097/SLA.0000000000001908.

PMID:
27471841
43.

Osteoconduction in keratin-hydroxyapatite composite bone-graft substitutes.

Dias GJ, Mahoney P, Hung NA, Sharma LA, Kalita P, Smith RA, Kelly RJ, Ali A.

J Biomed Mater Res B Appl Biomater. 2017 Oct;105(7):2034-2044. doi: 10.1002/jbm.b.33735. Epub 2016 Jul 8.

PMID:
27388333
44.

Helm's Alee: Setting a New Course.

Kelly RJ.

J Leg Med. 2015 Apr-Jun;36(2):101-2. doi: 10.1080/01947648.2015.1168653. No abstract available.

PMID:
27128334
45.

Parental problem drinking and children's sleep: The role of ethnicity and socioeconomic status.

Kelly RJ, El-Sheikh M.

J Fam Psychol. 2016 Sep;30(6):708-19. doi: 10.1037/fam0000209. Epub 2016 Apr 21.

46.

Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial.

Planchard D, Kim TM, Mazieres J, Quoix E, Riely G, Barlesi F, Souquet PJ, Smit EF, Groen HJ, Kelly RJ, Cho BC, Socinski MA, Pandite L, Nase C, Ma B, D'Amelio A Jr, Mookerjee B, Curtis CM Jr, Johnson BE.

Lancet Oncol. 2016 May;17(5):642-50. doi: 10.1016/S1470-2045(16)00077-2. Epub 2016 Apr 11.

47.

Scientific Advances in Lung Cancer 2015.

Tsao AS, Scagliotti GV, Bunn PA Jr, Carbone DP, Warren GW, Bai C, de Koning HJ, Yousaf-Khan AU, McWilliams A, Tsao MS, Adusumilli PS, Rami-Porta R, Asamura H, Van Schil PE, Darling GE, Ramalingam SS, Gomez DR, Rosenzweig KE, Zimmermann S, Peters S, Ignatius Ou SH, Reungwetwattana T, Jänne PA, Mok TS, Wakelee HA, Pirker R, Mazières J, Brahmer JR, Zhou Y, Herbst RS, Papadimitrakopoulou VA, Redman MW, Wynes MW, Gandara DR, Kelly RJ, Hirsch FR, Pass HI.

J Thorac Oncol. 2016 May;11(5):613-638. doi: 10.1016/j.jtho.2016.03.012. Epub 2016 Mar 22. Review.

48.

Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy.

Illei PB, Alewine C, Zahurak M, Cowan ML, Montgomery E, Hassan R, Xiang L, Pastan I, Kelly RJ.

Appl Immunohistochem Mol Morphol. 2016 Apr;24(4):246-52. doi: 10.1097/PAI.0000000000000292.

49.

Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma.

Thompson ED, Zahurak M, Murphy A, Cornish T, Cuka N, Abdelfatah E, Yang S, Duncan M, Ahuja N, Taube JM, Anders RA, Kelly RJ.

Gut. 2017 May;66(5):794-801. doi: 10.1136/gutjnl-2015-310839. Epub 2016 Jan 22.

50.

State of the art management of metastatic gastroesophageal cancer.

Murphy AG, Lynch D, Kelly RJ.

Ann Transl Med. 2015 Sep;3(16):236. doi: 10.3978/j.issn.2305-5839.2015.09.19. Review.

Supplemental Content

Loading ...
Support Center